Innovative Blood Collection Velano Vascular’s needle-free, patient-friendly PIVO device addresses a key need in hospital inpatient care by reducing pain and anxiety associated with traditional blood draws, offering a compelling value proposition for healthcare providers focused on patient experience and safety.

Strategic Hospital Partnerships The company has established relationships with leading hospital systems such as Intermountain Healthcare, Sutter Health, and Northwestern Medicine, indicating a strong foothold and potential opportunities to expand utilization of PIVO across additional hospital networks with similar patient safety and clinical efficiency priorities.

Market Recognition and Innovation Velano Vascular received notable industry awards, including Fast Company’s Most Innovative Companies, positioning it as a forward-thinking brand appealing to hospitals invested in adopting cutting-edge, clinically superior technologies to improve patient care.

Recent Growth and Funding With recent funding of $25 million and recognition as the fastest-growing medical device company in 2020, Velano Vascular demonstrates strong growth potential, making it an attractive prospect for sales teams targeting expanding hospital systems and health networks seeking innovative vascular access solutions.

Acquisition and Expansion Support Following its acquisition by Becton, Dickinson and Company in 2021, Velano Vascular benefits from increased resources, distribution channels, and credibility, creating opportunities for upselling or broadening product integration within broader hospital supply and equipment contracts.